{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:07:06Z","timestamp":1790510826561,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21702061"],"award-info":[{"award-number":["21702061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21672064"],"award-info":[{"award-number":["21672064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81522045"],"award-info":[{"award-number":["81522045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Yang-Fan Program from the Science and Technology Commission of Shanghai","doi-asserted-by":"publisher","award":["17YF1403600"],"award-info":[{"award-number":["17YF1403600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.08.025","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T15:16:30Z","timestamp":1502378190000},"page":"33-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Yi-xiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-nan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-duan-yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.08.025_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"Alzheimer's disease facts and figures","volume":"9","author":"Association","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2017.08.025_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A\u00a0century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.08.025_bib3","unstructured":"Alzheimer's Disease International, World Alzheimer Report. http:\/\/www.alz.co.uk\/research\/files\/WorldAlzheimerReport2015ExecutiveSummary.pdf (accessed April 24, 2016)."},{"key":"10.1016\/j.ejmech.2017.08.025_bib4","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","article-title":"Acetylcholinesterase in Alzheimer's disease","volume":"122","author":"Talesa","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2017.08.025_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.08.025_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal","volume":"9","author":"Hardy","year":"2006","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2017.08.025_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.08.025_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-2009-1068","article-title":"Challenges associated with metal chelation therapy in Alzheimer's disease","volume":"17","author":"Hegde","year":"2009","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2017.08.025_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/med.20148","article-title":"Chelation therapy for neurodegenerative diseases","volume":"29","author":"Bolognin","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2017.08.025_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejmech.2017.08.025_bib11","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/cbic.200900309","article-title":"hChAT: a tool for the chemoenzymatic generation of potential acetyl\/butyrylcholinesterase inhibitors","volume":"10","author":"Green","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2017.08.025_bib12","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1021\/jm070154q","article-title":"Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation","volume":"51","author":"Xie","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib13","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2174\/092986708785909067","article-title":"Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease","volume":"15","author":"Munoz-Torrero","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A\u00a0review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.ejmech.2017.08.025_bib15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1586\/ern.11.132","article-title":"Use of memantine for the treatment of dementia","volume":"11","author":"Lo","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2017.08.025_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/gps.1402","article-title":"A\u00a0systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease","volume":"21","author":"Takeda","year":"2006","journal-title":"Int. J. Geriatr. Psychopharmacol."},{"key":"10.1016\/j.ejmech.2017.08.025_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","article-title":"Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline","volume":"148","author":"Raina","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2017.08.025_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.ejmech.2017.08.025_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1531-8257(199903)14:2<219::AID-MDS1003>3.0.CO;2-9","article-title":"Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease","volume":"14","author":"Mellick","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2017.08.025_bib20","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2174\/0929867043364784","article-title":"Structure and mechanism of monoamineoxidase","volume":"11","author":"Edmondson","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/0929867305666220314202430","article-title":"Structural aspects of monoamine oxidase and its reversible inhibition","volume":"5","author":"Wouters","year":"1998","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2017.08.025_bib23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0024-3205(80)90025-9","article-title":"Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type","volume":"27","author":"Adolfsson","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2017.08.025_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0161-813X(03)00106-2","article-title":"Monoamine oxidase-B inhibition in Alzheimer's disease","volume":"25","author":"Riederer","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejmech.2017.08.025_bib25","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/jm801496u","article-title":"Synthesis, Molecular Modeling, and Selective Inhibitory Activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins","volume":"52","author":"Chimenti","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib26","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1021\/jm200716y","article-title":"Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors","volume":"54","author":"Matos","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JAD-2010-100150","article-title":"Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation","volume":"21","author":"Bar-Am","year":"2010","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2017.08.025_bib28","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1039\/C4CS00005F","article-title":"Cholesterol and metal ions in Alzheimer's disease","volume":"43","author":"Lee","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2017.08.025_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10534-006-9033-z","article-title":"Metals ions and neurodegeneration","volume":"20","author":"Molina-Holgado","year":"2007","journal-title":"BioMetals"},{"key":"10.1016\/j.ejmech.2017.08.025_bib30","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1074\/jbc.M313572200","article-title":"Copper binding to the amyloid-\u03b2 (A\u03b2) peptide associated with Alzheimer's disease","volume":"279","author":"Syme","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib31","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.biochi.2009.03.013","article-title":"Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease","volume":"91","author":"Hureau","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2017.08.025_bib32","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1002\/anie.200803908","article-title":"Structural studies of Copper(I) complexes of amyloid-\u03b2 peptide fragments: formation of two-coordinate Bis(histidine) complexes","volume":"47","author":"Himes","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2017.08.025_bib33","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1021\/ja907045h","article-title":"Small molecule modulators of copper-induced Abeta aggregation","volume":"131","author":"Hindo","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.08.025_bib34","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.ccr.2012.03.008","article-title":"The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases","volume":"256","author":"Rodriguez-Rodriguez","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2017.08.025_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","article-title":"Oxidative stress hypothesis in Alzheimer's disease: a reappraisal","volume":"29","author":"Pratico","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2017.08.025_bib36","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/ern.10.74","article-title":"Antioxidant approaches for the treatment of Alzheimer's disease","volume":"10","author":"Lee","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2017.08.025_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-Directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib38","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","article-title":"Design, synthesis and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer's disease","volume":"58","author":"Wang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03033355","article-title":"Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs: ladostigil","volume":"10","author":"Youdim","year":"2006","journal-title":"Neurotoxic. Res."},{"key":"10.1016\/j.ejmech.2017.08.025_bib40","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1021\/jm020120c","article-title":"Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease","volume":"45","author":"Sterling","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejmech.2013.01.039","article-title":"A\u00a0novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease","volume":"62","author":"Lu","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib42","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1021\/acs.jmedchem.6b00636","article-title":"Development of multifunctional pyrimidinylthiourea derivatives as potential anti-alzheimer agents","volume":"59","author":"Li","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2013.09.037","article-title":"Effects of the neurotoxin MPTP and pargyline protection on extracellular energy metabolites and dopamine levels in the striatum of freely moving rats","volume":"1538","author":"Bazzu","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2017.08.025_bib44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol. Amst. Neth."},{"key":"10.1016\/j.ejmech.2017.08.025_bib45","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/bi990438f","article-title":"The A\u03b2 peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction","volume":"38","author":"Huang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2017.08.025_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/jf0305231","article-title":"Extending applicability of the oxygen radical absorbance capacity (ORAC\u2212Fluorescein) assay","volume":"52","author":"Davalos","year":"2004","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib47","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1021\/jf010586o","article-title":"Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe","volume":"49","author":"Ou","year":"2001","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib48","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/cbic.200700111","article-title":"Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state","volume":"8","author":"Guilloreau","year":"2007","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2017.08.025_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib50","doi-asserted-by":"crossref","first-page":"21990","DOI":"10.1073\/pnas.1006091107","article-title":"Design of small molecules that target metal-A\u03b2 species and regulate metal-induced A\u03b2 aggregation and neurotoxicity","volume":"107","author":"Choi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.08.025_bib51","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1039\/C4OB00998C","article-title":"New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol","volume":"12","author":"Mao","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.025_bib52","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1083\/jcb.150.6.1423","article-title":"Activity- and Ca2+-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons","volume":"150","author":"Du","year":"2000","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2017.08.025_bib53","first-page":"413","article-title":"Effects of synthetic (-)-huperzine A on cholinesterase activities and mouse water maze performance","volume":"19","author":"Liu","year":"1998","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2017.08.025_bib54","series-title":"Schr\u00f6dinger Suite","year":"2016"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417306281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417306281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T20:42:45Z","timestamp":1659300165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417306281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":54,"alternative-id":["S0223523417306281"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.025","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}